Here's How Much $100 Invested In Halozyme Therapeutics 15 Years Ago Would Be Worth Today
Halozyme Therapeutics (NASDAQ:HALO) has outperformed the market over the past 15 years by 2.54% on an annualized basis producing an average annual return of 14.44%. Currently, Halozyme Therapeutics has a market capitalization of $6.72 billion.
Buying $100 In HALO: If an investor had bought $100 of HALO stock 15 years ago, it would be worth $764.94 today based on a price of $54.54 for HALO at the time of writing.
Halozyme Therapeutics's Performance Over Last 15 Years
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted-In: BZI-PODNews Trading Ideas